Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | PARP1 | P09874 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.35 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18229943 | 0.98 | ALDH1A1 (0.42) | ALDH1A1LTA4HSIGMAR1PARP1SMN1; SMN2 | |
| SCHEMBL17105914 | 0.87 | ALDH1A1 (0.39) | ALDH1A1SIGMAR1PARP1SMN1; SMN2TAS1R3 | |
| SCHEMBL15921707 | 0.83 | LTA4H (0.42) | ALDH1A1LTA4HSIGMAR1SMN1; SMN2TAS1R3 | |
| SCHEMBL3271284 | 0.82 | SIGMAR1 (0.48) | ALDH1A1LTA4HSIGMAR1PARP1SMN1; SMN2 | |
| SCHEMBL15921250 | 0.81 | ALDH1A1 (0.41) | ALDH1A1SIGMAR1SMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL9617576 | 0.81 | LMNA (0.42) | ALDH1A1SIGMAR1SMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL18756244 | 0.79 | LTA4H (0.35) | ALDH1A1LTA4HSIGMAR1PARP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7048748 | 0.79 | MEN1 (0.52) | ALDH1A1SIGMAR1SMN1; SMN2LMNAMAPK1 | |
| SCHEMBL15841457 | 0.79 | ALDH1A1 (0.35) | ALDH1A1SIGMAR1SMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL18461234 | 0.77 | PARP1 (0.38) | ALDH1A1LTA4HSIGMAR1PARP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3294447-B1 | MOLECULARLY IMPRINTED POLYMERS | PHASE HOLOGRAPHIC IMAGING PHI AB (SE) | 2023-12-06 | — | — | EP | claimed |
| US-9783671-B2 | Cross-linked plastic material with an intrinsic antimicrobial effect based on unsaturated polyesters | Fachhochschule Münster (DE) | 2017-10-10 | — | — | US | claimed |
| EP-4268855-A1 | TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID | Mochida Pharmaceutical Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-9803091-B2 | Cross-linked plastic material with an intrinsic antimicrobial effect based on vinyl esters and vinyl ester urethanes | Fachhochschule Münster (DE) | 2017-10-31 | — | — | US | disclosed |
| US-9803091-B2 | Cross-linked plastic material with an intrinsic antimicrobial effect based on vinyl esters and vinyl ester urethanes | Fachhochschule Münster (DE) | 2017-10-31 | — | — | US | disclosed |
| US-9803091-B2 | Cross-linked plastic material with an intrinsic antimicrobial effect based on vinyl esters and vinyl ester urethanes | Fachhochschule Münster (DE) | 2017-10-31 | — | — | US | disclosed |
| US-9783671-B2 | Cross-linked plastic material with an intrinsic antimicrobial effect based on unsaturated polyesters | Fachhochschule Münster (DE) | 2017-10-10 | — | — | US | disclosed |
| US-9783671-B2 | Cross-linked plastic material with an intrinsic antimicrobial effect based on unsaturated polyesters | Fachhochschule Münster (DE) | 2017-10-10 | — | — | US | disclosed |
| US-9783671-B2 | Cross-linked plastic material with an intrinsic antimicrobial effect based on unsaturated polyesters | Fachhochschule Münster (DE) | 2017-10-10 | — | — | US | disclosed |
| EP-2951245-B1 | CROSSLINKED PLASTIC MATERIAL WITH INTRINSIC ANTIMICROBIAL EFFECT ON THE BASIS OF UNSATURATED POLYESTER | Fachhochschule Münster (DE) | 2017-08-02 | — | — | EP | disclosed |
| EP-2951245-B1 | CROSSLINKED PLASTIC MATERIAL WITH INTRINSIC ANTIMICROBIAL EFFECT ON THE BASIS OF UNSATURATED POLYESTER | Fachhochschule Münster (DE) | 2017-08-02 | — | — | EP | disclosed |
| WO-2014118312-A1 | CROSS-LINKED PLASTIC MATERIAL WITH AN INTRINSICALLY ANTIMICROBIAL EFFECT BASED ON VINYL ESTERS AND VINYL ESTER URETHANES | Fachhochschule Münster (DE) | 2014-08-07 | — | — | WO | disclosed |
| WO-2014118312-A1 | CROSS-LINKED PLASTIC MATERIAL WITH AN INTRINSICALLY ANTIMICROBIAL EFFECT BASED ON VINYL ESTERS AND VINYL ESTER URETHANES | Fachhochschule Münster (DE) | 2014-08-07 | — | — | WO | disclosed |
| WO-2014118314-A1 | CROSS-LINKED PLASTIC MATERIAL WITH AN INTRINSIC ANTI-MICROBIAL EFFECT BASED ON UNSATURATED POLYESTER | Fachhochschule Münster (DE) | 2014-08-07 | — | — | WO | disclosed |
| US-20140135485-A1 | 6-11 BICYCLIC KETOLIDE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| US-20120035352-A1 | 6-11 Bicyclic Ketolide Derivatives | OR YAT SUN (US) | 2012-02-09 | — | — | US | disclosed |
| US-20090324577-A1 | 6-11 Bicyclic Ketolide Derivatives | OR YAT SUN | 2009-12-31 | — | — | US | disclosed |
| US-20070244160-A1 | 6-11 Bicyclic Ketolide Derivatives | OR YAT SUN | 2007-10-18 | — | — | US | disclosed |
| US-7273853-B2 | 6-11 bicyclic ketolide derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2007-09-25 | — | — | US | disclosed |
| US-7189704-B2 | 6-11 bicyclic ketolide derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2007-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135485-A1 | 6-11 BICYCLIC KETOLIDE DERIVATIVES | AKR1C2, AKR1C3, AKR1C1 | ALDH1A1 452/4885LTA4H 414/4885SIGMAR1 2186/4885 |
| US-20120035352-A1 | 6-11 Bicyclic Ketolide Derivatives | AKR1C2, AKR1C3, AKR1C1 | ALDH1A1 452/4885LTA4H 414/4885SIGMAR1 2186/4885 |
| US-20070244160-A1 | 6-11 Bicyclic Ketolide Derivatives | AKR1C2, AKR1C3, AKR1C1 | ALDH1A1 452/4885LTA4H 414/4885SIGMAR1 2186/4885 |
| US-20090324577-A1 | 6-11 Bicyclic Ketolide Derivatives | AKR1C2, AKR1C3, AKR1C1 | ALDH1A1 452/4885LTA4H 414/4885SIGMAR1 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.